Check out the Broad's Tumor Portal from Gad Getz’s group for genes, cancers, and mutations. http://t.co/DpdWI66cCm HT @boehmjesse
— Broad Institute (@broadinstitute) February 10, 2014
http://cancergenome.broadinstitute.org |
SF: @broadinstitute will generate more sequence in 2014 than all previous years combined. Exciting times for us analysis types! #AGBT14
— Daniel MacArthur (@dgmacarthur) February 13, 2014
Seshagiri: ERBB3 mutations increased in colon cancer result in ligand independent activation requiring ERBB2 - targetable with mAb #AGBT14
— Ion Torrent (@iontorrent) February 14, 2014
Aucun commentaire:
Enregistrer un commentaire